Difluprednate

二氟泼尼酯

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameDifluprednate
Drug Alias Namedifluprednato双氟泼尼酯difluprednatum二氟孕甾丁酯difluprednate +[11] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPostoperative inflammationPain, ProceduralPain, Postoperative +[9] 
Global Approved IndicationsPostoperative inflammationPain, Postoperative
Approved Indications in ChinaPostoperative inflammationPain, Postoperative
Original Approved Country/TerritoryJapan
Original Approved Date1986/07/01
Country/TerritoryCanadaUnited StatesMexico +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharmaceuticals Canada IncShenzhen Kangzhe Biotechnology Co LtdSandoz +[6] 
Inactive CompaniesLaboratorios Sophia Sa De CvAlconSirion Therapeutics Inc
Active IndicationsPostoperative inflammationPain, ProceduralPain, Postoperative +[5] 
Inactive IndicationsPanuveitisUveitisCataract +[4] 

Other Information

ATC CodeD07AC19
Related LinksWikipediaDrugBankKEGG